Spots Global Cancer Trial Database for recombinant immunotoxin
Every month we try and update this database with for recombinant immunotoxin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma | NCT01445392 | Mesothelioma | Multicycle SS1P Pemetrexed Cisplatin Single cycle SS... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia | NCT03805932 | Hairy Cell Leuk... | Moxetumomab Pas... Rituximab Ruxience Dexamethasone Acetaminophen Diphenhydramine Famotidine Aspirin | 18 Years - | National Institutes of Health Clinical Center (CC) | |
SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma | NCT01445392 | Mesothelioma | Multicycle SS1P Pemetrexed Cisplatin Single cycle SS... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia | NCT00117845 | Leukemia, Adult... | Denileukin dift... | 18 Years - | National Institutes of Health Clinical Center (CC) |